Cytomegalovirus infection in AIDS. Patterns of disease, response to therapy and trends in survival

Journal of Infection

Volumn 23, Issue 2, 1991, Pages 129-137

  Peters, B S ^a   Beck, E J ^a   Anderson, S ^a   Coleman, D ^a   Coker, R ^a   Main, J ^a   Migdal, C ^a   Harris, J R W ^a   Pinching, A J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COLITIS; CYTOMEGALOVIRUS INFECTION; DEATH; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUTROPENIA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETINITIS; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIVIRAL AGENTS; COLITIS; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOSCARNET; GANCICLOVIR; HUMAN; LONDON; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; PHOSPHONOACETIC ACID; PREVALENCE; RECURRENCE; RETINITIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTOPENIA; ZIDOVUDINE;

EID: 0026091361     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-4453(91)91987-9     Document Type: Article

References (35)

1. Preliminary results of a therapeutic trial of DHPG for cytomegalovirus infections in AIDS patients
2. Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS; clinical manifestations and preliminary report of treatment with foscarnet (phosphonoformate)
3. Acquired immune deficiency syndrome: ocular manifestations
4. Acquired immunodeficiency syndrome: ocular manifestations in ambulatory patients
5. Retinal manifestations of the acquired immune deficiency syndrome (AIDS): cytomegalovirus, Candida albicans, cryptococcus, toxoplasmosis and Pneumocystis carinii
6. Ophthalmologic findings in acquired immune deficiency syndrome (AIDS)
7. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome
8. Microvascular aspects of acquired immune syndrome retinopathy
9. Ophthalmic involvement in acquired immunodeficiency syndrome
10. Ocular manifestations of acquired immune deficiency syndrome
11. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome
12. Cytomegalovirus retinitis and acquired immunodeficiency syndrome
13. Treatment of serious cytomegalovirus infections with 9-(I3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies
14. Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on serious cytomegalovirus disease in eight immunosuppressed homosexual men
15. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine
16. Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine
17. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts
18. Cytomegalovirus retinitis and response to therapy with ganciclovir
19. Treatment of cytomegalovirus retinopathy with ganciclovir
20. Treatment of cytomegalovirus retinitis with ganciclovir
21. Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS
22. Combined short- and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)
23. Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy
24. Ganciclovir treatment of life or sight threatening cytomegalovirus infection: experience in 314 immunocompromised patients
25. Three times a week maintenance ganciclovir to prevent relapse of CMV retinitis in AIDS
26. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex
27. Changing disease patterns in people with AIDS in a referral centre in the United Kingdom: the changing face of AIDS
28. Acyclovir for prevention of cytomegalovirus infection and disease after allogenic marrow transplantation
29. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts
30. Usefulness of high dose acyclovir as prophylaxis for CMV
31. Effects of long-term subcutaneous administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with HIV-related leukopenia
32. Granulocytemacrophage colony stimulating factor ameliorates the neutropenia induced by azidothymidine in AIDS/ARC patients
33. Cytokines alter production of HIV-1 from primary mononuclear phagocytes
34. Human pharmacokinetics and tolerance of oral ganciclovir
35. Feasibility trial for outpatient induction with ganciclovir